Adrenomedullin as an immunomodulator of CD14+MerTK+ circulating monocytes in liver failure syndromes
Adrenomedullin is increased in acute liver failure syndromes (ALF and ACLF), and AMBP1 is, on the contrary, reduced, mirroring the severity of the disease expressed by the SOFA score. ADM affects ...
Brain macrophages serve diversified niches in the brain to maintain the organ’s homeostasis, and can play pathogenic roles in age-related brain disease. Hoping to one day replace dysfunctional ...
Economic impact of progressive disease (PD) following frontline therapy in classical Hodgkin lymphoma (HL). This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not ...
(from left) Dr. Ibrahim Hawwari, Prof. Bernardo Franklin and Lukas Roßnagel discover new intercellular communication mechanism in which blood platelets, so-called thrombocytes, regulate the function ...
A new report builds on previous research that could help scientists better understand type 1 diabetes (T1D) risk. Altered levels and activity of monocytes appear to correlate with the progression of ...
University of Manchester immunologists are the first to make an interesting observation about the white blood cells of patients with COVID-19. A particular subset of these cells, called monocytes, ...
Cedars-Sinai Research Suggests That Targeting Alzheimer's Disease With Specialized Immune Cells Might Someday Have Therapeutic Effects in Humans Los Angeles - July 6, 2015 – Cedars-Sinai researchers ...
Liver failure syndromes are characterized by a dysregulated immune response leading to immune paralysis. Adrenomedullin (ADM) is a potent vasodilator and immunoregulator. This study aimed to explore ...
A new study published on the preprint server medRxiv* in June 2020 shows that the drug hydroxychloroquine (HCQ) suppresses a form of immunity called ‘trained immunity,’ with repercussions for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results